A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial

Yuxiang Ma(Sun Yat-sen University), Hongyun Zhao(Sun Yat-sen University), Yuanyuan Zhao(East China University of Science and Technology), Yunpeng Yang(Sun Yat-sen University), Yanqiu Zhao(Harbin Medical University), Seth Rosen(Hematology Oncology Associates), Siqing Fu(The University of Texas MD Anderson Cancer Center), Wen‐Feng Fang(Sun Yat-sen University), Bihui Li(Guilin Medical University), Dongqing Lv(Wenzhou Medical University), David Sommerhalder(Texas Oncology), Xianzhong Zhang, Tongtong Xue(Beijing Institute of Technology), Lin Wu(Materials Systems (United States)), Kunyu Yang(Macau University of Science and Technology), Shen Zhao(Sun Yat-sen University), Peng Zhang(University of Science and Technology of China), Jianjun Liu(University of Kentucky), Zhihua Liu(Hefei University of Technology), Li Zhang(Jinan Stomatological Hospital), Jinhui Xue(Zhengzhou Central Hospital), Mingjun Li(Northwest A&F University), Zhuang Wu(Wuhan University of Technology), Yun Fan(Zhejiang Cancer Hospital), Yan Huang(Qilu Hospital of Shandong University), Yulong Zheng(First Affiliated Hospital Zhejiang University), Yinghua Ji(First Affiliated Hospital of Xinxiang Medical University), Jingao Li(Jiangxi Provincial Cancer Hospital), Suxia Luo(Zhengzhou University), S Q Qu(Guangxi Medical University), Jiaqiang Cai, Wei Lian(Yantaishan Hospital), Shaodong Hong(Sun Yat-sen University), Shujun Yang(Henan Cancer Hospital), Steve Chin(Unknown), Yang Zhang(Qinghai University), Xiangjiao Meng(Shandong First Medical University)
Nature Medicine
March 13, 2025
Cited by 76


Related Papers